Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Fujifilm Diosynth Biotechnologies
Pharma
Enhertu, Akeso, Fujifilm-Regeneron—Fierce Pharma Asia
Enhertu delivered a positive readout in first-line breast cancer. Akeso's ivonescimab bagged another phase 3 win. Fujifilm signed a 10-year deal with Regeneron.
Angus Liu
Apr 25, 2025 8:45am
Regeneron taps Fujifilm Diosynth for $3B production agreement
Apr 22, 2025 10:03am
Takeda, Enhertu, East Asian American execs—Fierce Pharma Asia
Jan 31, 2025 8:53am
Fujifilm Diosynth CEO marks 2025 as era of expansion execution
Jan 24, 2025 12:12pm
Leqembi, Takeda, Fujifilm Diosynth—Fierce Pharma Asia
Apr 19, 2024 9:20am
Fujifilm Diosynth's restructuring may leave 240 out of work
Apr 17, 2024 12:10pm
